PALISADE BIO, INC. — Director's Dealing 2015

Jul 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-07-24

Reporting Person: GARR RICHARD (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-24	Common Stock	M	800000	$0.50	Acquired	1883337	Direct
2015-07-24	Common Stock	F	380263	$1.93	Disposed	1503074	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-24	Common Stock purchase option	$0.50	M	800000	Disposed	2015-07-27	Common Stock (800000)	Direct

Footnotes

F1: Represents 173,009 shares forfeited for tax witholding purposes and 207,254 shares withheld by the Issuer at the market price of $1.93 per share less an exercise price of $0.50 per share to fund the cashless exercise of 800,000 options. The total number of shares issued to Reporting Person pursuant to the cashless exercise of the options is 419,737.

F2: Represents option issued on July 28, 2005. The option was exercised on a cashless basis on 7/24/2015.